Portal de investigación
Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Calderón A.T.
- Garcia-Garcia H.M.
Grupos
Abstract
[No abstract available]
Datos de la publicación
- ISSN/ISSNe:
- 0098-7484, 1538-3598
- Tipo:
- Letter
- Páginas:
- 891-
- PubMed:
- 36066524
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 6,076 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION AMER MEDICAL ASSOC
Documentos
- No hay documentos
Filiaciones
Keywords
- Antibodies, Monoclonal, Humanized; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Treatment Outcome; alirocumab; hydroxymethylglutaryl coenzyme A reductase inhibitor; alirocumab; ezetimibe; hydroxymethylglutaryl coenzyme A reductase inhibitor; low density lipoprotein cholesterol; placebo; rosuvastatin; alirocumab; hydroxymethylglutaryl coenzyme A reductase inhibitor; monoclonal antibody; acute heart infarction; clinical feature; coronary artery atherosclerosis; human; Letter; optical coherence tomography; risk factor; acute heart infarction; clinical outcome; coronary atherosclerosis; drug effect; echography; high risk patient; low density lipoprotein cholesterol level; complication; coronary artery disease; heart infarction; treatment outcome
Campos de Estudio
Cita
Calderón AT,Sanz J,Garcia HM. Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction. JAMA. 2022. 328(9):p. 891-891. IF:120,700. (1).